These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 772595)

  • 1. [Treatment of hyaline membrane disease with the plasminogen urokinase combination].
    Leroux B; Rose JP; Potron G; Grun G; Droulle C; Mesmin F; Gomes H
    Nouv Presse Med; 1976 Mar; 5(11):699-702. PubMed ID: 772595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome (ARDS), caused by trauma and/or septic shock in patients and in experimental animals.
    Ambrus JL; Ambrus CM
    J Med; 1990; 21(1-2):67-84. PubMed ID: 2145377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of hyaline membrane disease with plasminogen. Preliminary report of a cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP
    Res Commun Chem Pathol Pharmacol; 1976 Sep; 15(1):195-8. PubMed ID: 788079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Value of Lysyl-plasminogen-urokinase sequential treatment in thrombolytic therapy].
    Brochier M; Planiol T; Griguer P; Raynaud P; Fauchier JP; Charbonnier B; Latour F; Pellois A
    Coeur Med Interne; 1977; 16(4):513-21. PubMed ID: 589966
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of acute pulmonary embolism with urokinase compared with the combination plasminogen-urokinase. Apropos of 67 cases].
    François G; Charbonnier B; Raynaud P; Garnier LF; Griguer P; Brochier M
    Arch Mal Coeur Vaiss; 1986 Apr; 79(4):435-42. PubMed ID: 3090961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen in the prevention of hyaline membrane disease.
    Ambrus CM; Weintraub DH; Choi TS; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Irwin ; Bross DJ; Jung OS; Mink IB; Ambrus JL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):341-4. PubMed ID: 4582209
    [No Abstract]   [Full Text] [Related]  

  • 7. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment with the urokinase-lysyl plasminogen combination of developmental outbreaks of arteriopathies].
    Vitoux JF; Roncato M; Pernes JM; Fiessinger JN; Aiach M; Gaux JC
    Ann Med Interne (Paris); 1986; 137(2):105-7. PubMed ID: 3717814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indications and results of thrombolytic treatment with urokinase of very severe pulmonary embolism].
    Brochier M; Raynaud R; Griguer P; Faucchier JP; Morand P
    Boll Soc Ital Cardiol; 1973; 18(7):693-6. PubMed ID: 4620067
    [No Abstract]   [Full Text] [Related]  

  • 10. [Fibrinolytic treatment of acute respiratory insufficiency (shock lung) after diagnostic amniocentesis with septic shock].
    Heyes H; Jonatha W; Knoche E; Traub E
    Dtsch Med Wochenschr; 1979 Jul; 104(28):1017-8. PubMed ID: 378633
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urokinase in acute and chronic arterial diseases].
    Ciammaichella A; Gori M; Bonacci I
    Clin Ter; 1981 Nov; 99(4):377-81. PubMed ID: 7030591
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thrombolytic therapy with urokinase. Clinical trials].
    Bizzi B; Leone G; Tutinelli F; Landolfi R
    Clin Ter; 1978 Sep; 86(5):419-32. PubMed ID: 737966
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment by urokinase of myocardial infarction and threatened infarction. Randomised study of 120 cases].
    Brochier M; Raynaud R; Planiol T; Fauchier JP; Griguer P; Archambaud D; Pellois A; Clisson M
    Arch Mal Coeur Vaiss; 1975 Jun; 68(6):563-9. PubMed ID: 810098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of exogenous surfactants on mortality and main complications of hyaline membrane disease].
    Walti H; Relier JP
    Pediatrie; 1990; 45(10):657-63. PubMed ID: 2177543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental and clinical studies on oral urokinase and lysyl-plasminogen. Thrombolytic therapy for cerebral thrombosis].
    Naito I
    Rinsho Ketsueki; 1984 Jul; 25(7):1027-35. PubMed ID: 6389929
    [No Abstract]   [Full Text] [Related]  

  • 16. [Occlusion of the retinal vein: anticoagulants and fibrinolytics (urokinase). Initial results of a randomized study].
    Coscas G; Soubrane G
    Bull Soc Ophtalmol Fr; 1978 Oct; 78(10):737-42. PubMed ID: 380835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombolytic treatment of deep leg and pelvic vein thromboses].
    Breddin HK; Krzywanek HJ
    Internist (Berl); 1982 Jul; 23(7):410-6. PubMed ID: 7050003
    [No Abstract]   [Full Text] [Related]  

  • 18. [Thrombolytic efficacy of a Lys-plasminogen-urokinase combination: studies in experimental animals and humans].
    Latorre J; Foncuberta J; Rosendo A; Elez J
    Angiologia; 1990; 42(6):218-26. PubMed ID: 2075946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic therapy for venous thrombosis in patients with gastro-intestinal diseases.
    Pogliani EM; Bozzani A; Radaelli F; Conte D; Bardella MT; Colombi M; Quatrini M
    Pharmatherapeutica; 1982; 3(4):268-73. PubMed ID: 6755491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fibrinolysin system and its relationship to disease in the newborn.
    Ambrus CM; Ambrus JL; Choi TS; Jung O; Mirand EA; Bartfay-Szabo A
    Am J Pediatr Hematol Oncol; 1979; 1(3):251-60. PubMed ID: 161694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.